Top 50 Most Viewed Posts This Week |
Today This Week Last Week This Month Last Month
|
1. My69z: Sell before putting iP value into the company, (1181) (14) |
2. ohm20: ohm: how reasonable would it be to assume that (744) (10) |
3. ohm20: It is not a question of if "these guys are not (680) (18) |
4. dfwl28: https://www.nytimes.com/2024/05/08/technology/goo (605) (8) |
5. rodolfo: Well then, I'd be intersted in your opinion why (587) (2) |
6. My69z: Another Dr. Burger Patent: Date of Patent: (577) (6) |
7. dfwl28: White Paper/ Journal publications. Hopefully. (574) (4) |
8. generactor: I think it's probably the opposite because if an (569) (9) |
9. Mrkev: Speaking of synergies as Figgs suggested, Just (559) (2) |
10. Harpitdown: Not gonna lie...I don't hate (553) (3) |
11. biloxiblues: https://www.trademarkelite.com/trademark/trademar (552) (6) |
12. ohm20: It does appear that Leronlimab is available again (549) (15) |
13. Evil Rabbit: It does appear that Leronlimab is available again (549) (18) |
14. USS JOHNSTON: "Ohmlimab?" (548) (11) |
15. ohm20: New' genetic Alzheimer's disease may impact 6.7 (539) (27) |
16. SamaGong: Great post, Ohm. CCR5 has been studied a lot (538) (7) |
17. sean007: Eight months later...We have a Premie...named (536) (6) |
18. generactor: Looking at their client list, Borgers probably (535) (13) |
19. USS JOHNSTON: Question about the current company operations: (531) (2) |
20. Jake2212: ER: Pembrolizumab is the generic name for (529) (6) |
21. Katangolo: They are aware. (526) (2) |
22. sean007: Trademark Elite Serial # (516) (8) |
23. brentie: "Washington D.C., May 3, 2024 — The Securities (510) (5) |
24. Vintool: Wow! I see a few things in this article we have (509) (9) |
25. ohm20: Well, in the case of a cancer that has developed (509) (16) |
26. Chasing Stars: Getting started on Investors Hangout. Are you (508) (14) |
27. MGK_2: I appreciate the private chat, but if you want me (504) |
28. biloxiblues: David F. Welch, Ph.D., is Founder and Chief (502) (6) |
29. chazzledazzle: Mixed feelings about Nader. I defended him (498) (8) |
30. craigakess: I think the question/point being missed here is (493) (10) |
31. Evil Rabbit: Many of us have had to make mea culpas about (491) (16) |
32. Figgs: My guess, and this could happen at any time, is (488) (7) |
33. FKAdamF.: How do you know there has not been any offers? (487) (7) |
34. Mrkev: We all hope to be in MDGL’s position someday (484) (1) |
35. jfl97: I didn't know Borger's had been convicted of (483) (6) |
36. MLR_Lite: Happy to report a website update. May not be (479) (14) |
37. Drano: No, the original date for the arbitration was (479) (2) |
38. biloxiblues: More on Borgers! (477) (1) |
39. Jake2212: ohm: how reasonable would it be to assume that (476) (5) |
40. sean007: Different Folks...Different strokes...We can (475) (1) |
41. sean007: Nothing Burger...They can't play per the SEC...We (475) (6) |
42. docj: Well we are due for news. (472) (5) |
43. chazzledazzle: “Does anyone have a good feel for what might be (470) (3) |
44. sean007: Perhaps,... doctors looking for a remedy in the (468) (1) |
45. seemingly-harmless: madrigal gets to use "non invasive test" (non (468) (5) |
46. sean007: "Maybe these guys are not going to sell out"...NO (467) (7) |
47. MGK_2: Well, in the case of a cancer that has developed (465) (8) |
48. sean007: Once the Large Molecule has proven its (455) (3) |
49. dfwl28: Mixed feelings about Nader. I defended him (455) (3) |
50. armyseal: to add, like clockwork, Dalton does his usual pre (453) (5) |